Bio-Rad Labs (BIO) Tops Q3 EPS by 85c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $282.44 --0%
EPS Growth %: -30.7%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -30.7%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $2.01, $0.85 better than the analyst estimate of $1.16. Revenue for the quarter came in at $649.7 million versus the consensus estimate of $628.18 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- Qualcomm (QCOM) PT Raised to $200 at Cantor Fitzgerald
- Micron Technology (MU) call put ratio 1 calls to 1.1 puts into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
